Literature DB >> 412857

Synthesis of proteoglycans by suspension and monolayer cultures of adult chondrocytes and de novo cartilage nodules-the effect of hyaluronic acid.

O W Wiebkin, H Muir.   

Abstract

Chondrocytes were isolated from adult laryngeal cartilage by an enzymic procedure that included 6 h digestion with collagenase. The level of 35SO4(2-) incorporation into cetylpyridinium chloride-precipitable material by these cells depended upon the subsequent culturing conditions. Suspension cultures incorporated more 35SO4(2-)/cell than monolayer cultures. Hyaluronic acid in the medium inhibited 35SO4(2-) incorporation only when the cells were in primary suspension cultures. It had no effect on monolayer cultures, or monolayers organized into nodules, or suspension cultures derived from monolayers. Mild pretreatment with EDTA, however, rendered these susceptible to hyaluronic acid inhibition. In contrast EDTA abolished the inhibitory effect of hyaluronic acid on primary suspension cultures. Oligosaccharides, derived from hyaluronidase digestion of hyaluronic acid that were larger than decassaccharide, had some inhibitor effect on 35SO4(2-) incorporation by monolayer cultures. The total 35SO4(2-) incorporation was less in primary suspension cultures of chondrocytes isolated after 12 h than after 6 h digestion of cartilage and the inhibition by hyaluronic acid was also less. These differences persisted during 12 days of culture. It is suggested that the method of isolating chondrocytes and subsequent culture conditions may modify the cell surface and mask or abolish specific binding sites for hyaluronic acid.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412857     DOI: 10.1242/jcs.27.1.199

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  13 in total

1.  Expression of the human chondrocyte phenotype in vitro.

Authors:  A L Aulthouse; M Beck; E Griffey; J Sanford; K Arden; M A Machado; W A Horton
Journal:  In Vitro Cell Dev Biol       Date:  1989-07

2.  Regulation of human lung fibroblast glycosaminoglycan production by recombinant interferons, tumor necrosis factor, and lymphotoxin.

Authors:  J A Elias; R C Krol; B Freundlich; P M Sampson
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan.

Authors:  P Mahadevan; R G Larkins; J R Fraser; A J Fosang; M E Dunlop
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

4.  Antigenic profiles of human, bovine and canine articular chondrocytes.

Authors:  T Glant; K Mikecz
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

5.  The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment.

Authors:  M M Smith; P Ghosh
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

6.  Synthesis of sulphated proteoglycans by rheumatoid and normal synovial tissue in culture.

Authors:  J M Marsh; O W Wiebkin; S Gale; H Muir; R N Maini
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

7.  Specific interaction between cartilage proteoglycans and hyaluronic acid at the chondrocyte cell surface.

Authors:  Y Sommarin; D Heinegård
Journal:  Biochem J       Date:  1983-09-15       Impact factor: 3.857

8.  Isolation and culture techniques of foetal calf chondrocytes.

Authors:  S Björnsson; D Heinegård
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

9.  Mast cells and tumors. The specific enhancement of tumor proliferation in vitro.

Authors:  W R Roche
Journal:  Am J Pathol       Date:  1985-04       Impact factor: 4.307

10.  Four classes of cell-associated proteoglycans in suspension cultures of articular-cartilage chondrocytes.

Authors:  Y Sommarin; D Heinegård
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.